Business
NRX Pharmaceuticals Announces Data Sharing Agreement Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatment of Suicidal Bipolar Depression
Ketamine, an NMDA blocker, was highly effective in Bipolar subgroup
About this update from Nrx Pharmaceuticals, Inc.
[{"type":"text","content":"Ketamine, an NMDA blocker, was highly effective in Bipolar subgroup (p","length":90,"tagName":"div"}]